Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Pharmacoepidemiology and Drug Safety|October 10, 2025
Trajectories of Adherence to Biologics in Patients With Inflammatory Bowel Diseases: A Large-Scale Multi-Regional Italian Study Through the VALORE Distributed DatabaseSabrina Giometto, Andrea Spini, Giorgia Pellegrini, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohortLoreta A Kondili, Monica Monti, Maria Giovanna Quaranta, et al.
Expert Opinion on Biological Therapy|October 31, 2025
Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database networkFederica Soardo, Andrea Spini, Luca L'Abbate, et al.
Journal of Translational Medicine|October 22, 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 12, 2021
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE ProjectGianluca Trifirò, Valentina Isgrò, Ylenia Ingrasciotta, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 3, 2025
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database NetworkFederica Soardo, Andrea Spini, Giorgia Pellegrini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 15, 2018
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Loreta A Kondili, Sarah Robbins, Sarah Blach, et al.
Hepatology (Baltimore, Md.)|July 26, 2017
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohortLoreta A Kondili, Federica Romano, Francesca Romana Rolli, et al.
Pharmacological Research|April 22, 2026
Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: a target trial emulation using the Italian VALORE distributed database networkAndrea Spini, Luca L'Abbate, Ylenia Ingrasciotta, et al.
Pageof 13